Posted by Michael Wonder on 03 Nov 2022
Advocate 'gutted' as PHARMAC reviews blanket funding of child cancer medicines
2 November 2022 - Rule 8.1b of the Pharmaceutical Schedule allows all child cancer medicines to be funded by PHARMAC.
A rule which allows for blanket funding of cancer medicines to treat children is being reviewed by PHARMAC, to consider whether it is still “needed”.
